Literature DB >> 30637622

Pituitary dysfunction due to sports-related traumatic brain injury.

Aysa Hacioglu1, Fahrettin Kelestimur2, Fatih Tanriverdi3.   

Abstract

PURPOSE: After traumatic brain injury was accepted as an important etiologic factor of pituitary dysfunction (PD), awareness of risk of developing PD following sports-related traumatic brain injury (SR-TBI) has also increased. However there are not many studies investigating PD following SR-TBIs yet. We aimed to summarize the data reported so far and to discuss screening algorithms and treatment strategies.
METHODS: Recent data on pituitary dysfunction after SR-TBIs is reviewed on basis of diagnosis, clinical perspectives, therapy, screening and possible prevention strategies.
RESULTS: Pituitary dysfunction is reported to occur in a range of 15-46.6% following SR-TBIs depending on the study design. Growth hormone is the most commonly reported pituitary hormone deficiency in athletes. Pituitary hormone deficiencies may occur during acute phase after head trauma, may improve with time or new deficiencies may develop during follow-up. Central adrenal insufficiency is the only and most critical impairment that requires urgent detection and replacement during acute phase. Decision on replacement of growth hormone and gonadal deficiencies should be individualized. Moreover these two hormones are abused by many athletes and a therapeutic use exemption from the league's drug policy may be required.
CONCLUSIONS: Even mild and forgotten SR-TBIs may cause PD that may have distressing consequences in some cases if remain undiagnosed. More studies are needed to elucidate epidemiology and pathophysiology of PD after SR-TBIs. Also studies to establish screening algorithms for PD as well as strategies for prevention of SR-TBIs are urgently required.

Entities:  

Keywords:  Central hypogonadism; Growth hormone deficiency; Pituitary dysfunction; Sports-related traumatic brain injury

Mesh:

Substances:

Year:  2019        PMID: 30637622     DOI: 10.1007/s11102-019-00937-z

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  5 in total

Review 1.  The role of autoimmunity in pituitary dysfunction due to traumatic brain injury.

Authors:  Annamaria De Bellis; Giuseppe Bellastella; Maria Ida Maiorino; Angela Costantino; Paolo Cirillo; Miriam Longo; Vlenia Pernice; Antonio Bellastella; Katherine Esposito
Journal:  Pituitary       Date:  2019-06       Impact factor: 4.107

2.  Relationship between Anterior Pituitary Volume and IGF-1 Serum Levels in Soldiers with Mild Traumatic Brain Injury History.

Authors:  Anna K Castellano; Jacob R Powell; Michael J Cools; Samuel R Walton; Randaline R Barnett; Stephen M Delellis; Richard L Goldberg; Shawn F Kane; Gary E Means; Carlos A Zamora; Patrick J Depenbrock; Jason P Mihalik
Journal:  Med Sci Sports Exerc       Date:  2022-02-08

3.  A Calixarene Assembly Strategy of Combined Anti-Neuroinflammation and Drug Delivery Functions for Traumatic Brain Injury Therapy.

Authors:  Chunxiao Wang; Yu-Xuan Chang; Xi Chen; Lihuan Bai; Heping Wang; Yu-Chen Pan; Chunqiu Zhang; Dong-Sheng Guo; Xue Xue
Journal:  Molecules       Date:  2022-05-06       Impact factor: 4.927

4.  Hiding in Plain Sight: Factors Influencing the Neuroinflammatory Response to Sport-Related Concussion.

Authors:  Jason B Tabor; Michael A McCrea; Timothy B Meier; Carolyn A Emery; Chantel T Debert
Journal:  Neurotrauma Rep       Date:  2022-05-05

5.  Growth hormone deficiency testing and treatment following mild traumatic brain injury.

Authors:  Leah J Mercier; Natalia Kruger; Quynk B Le; Tak S Fung; Gregory A Kline; Chantel T Debert
Journal:  Sci Rep       Date:  2021-04-20       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.